Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
41.37
-2.28 (-5.22%)
At close: Nov 20, 2026, 4:00 PM EST
41.40
+0.03 (0.07%)
After-hours: Nov 20, 2026, 7:30 PM EST
Arrowhead Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $108 → $105 | Buy | Maintains | $108 → $105 | +153.81% | Nov 17, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 13, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $100 | Buy | Reiterates | $100 | +141.72% | Nov 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $120 → $106 | Buy | Maintains | $120 → $106 | +156.22% | Nov 13, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Reiterates $109 | Buy | Reiterates | $109 | +163.48% | Nov 13, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $104 → $96 | Buy | Maintains | $104 → $96 | +132.05% | Nov 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $126 | Buy | Reiterates | $126 | +204.57% | Nov 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +190.07% | Nov 11, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.